Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (abre uma nova janela)

Ball AM, Winstead PS.

Fonte‎: Pharmacotherapy 2008;28(11):1383-90.

Indexado‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (abre uma nova janela)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (abre uma nova janela)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Fonte‎: Transplant Proc 2015;47(8):2548-51.

Indexado‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (abre uma nova janela)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (abre uma nova janela)

Charles A, Purtill M, Napolitano LM.

Fonte‎: Anaesth Intensive Care 2006;34(6):793-6.

Indexado‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (abre uma nova janela)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (abre uma nova janela)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Fonte‎: Crit Care Med 1999;27(11):2346-50.

Indexado‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (abre uma nova janela)

The role of erythropoietin therapy in the critically ill. (abre uma nova janela)

Corwin HL.

Fonte‎: Transfus Med Rev 2006;20(1):27-33.

Indexado‎: PubMed 16373185

DOI‎: 10.1016/j.tmrv.2005.08.002

https://www.ncbi.nlm.nih.gov/pubmed/16373185 (abre uma nova janela)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (abre uma nova janela)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Fonte‎: Crit Care 2005;9(5):R508-15.

Indexado‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (abre uma nova janela)

Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. (abre uma nova janela)

Khalafallah AA, Yan C, Al-Badri R, Robinson E, Kirkby BE, Ingram E, Gray Z, Khelgi V, Robertson IK, Kirkby BP.

Fonte‎: Lancet Haematol 2016;3(9):e415-25.

Indexado‎: PubMed 27570088

DOI‎: 10.1016/S2352-3026(16)30078-3

https://www.ncbi.nlm.nih.gov/pubmed/27570088 (abre uma nova janela)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (abre uma nova janela)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Fonte‎: Intensive Care Med 2013;39(11):1896-908.

Indexado‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (abre uma nova janela)

An international consensus statement on the management of postoperative anaemia after major surgical procedures. (abre uma nova janela)

Muñoz M, Acheson AG, Bisbe E, Butcher A, Gómez-Ramírez S, Khalafallah AA, Kehlet H, Kietaibl S, Liumbruno GM, Meybohm P, Rao Baikady R, Shander A, So-Osman C, Spahn DR, Klein AA

Fonte‎: Anaesthesia 2018;73(11):1418-31.

Indexado‎: PubMed 30062700

DOI‎: 10.1111/anae.14358

https://www.ncbi.nlm.nih.gov/pubmed/30062700 (abre uma nova janela)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (abre uma nova janela)

Posluszny JA Jr, Napolitano LM.

Fonte‎: Transfusion 2014;54(12):3026-34.

Indexado‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (abre uma nova janela)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (abre uma nova janela)

Price S, Pepper JR, Jaggar SI.

Fonte‎: Anesth Analg 2005;101(2):325-7.

Indexado‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (abre uma nova janela)

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. (abre uma nova janela)

Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group.

Fonte‎: J Am Heart Assoc 2015;4(6):e002066.

Indexado‎: PubMed 26037084

DOI‎: 10.1161/JAHA.115.002066

https://www.ncbi.nlm.nih.gov/pubmed/26037084 (abre uma nova janela)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (abre uma nova janela)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Fonte‎: Br J Anaesth 2005;94(4):442-4.

Indexado‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (abre uma nova janela)

Transfusion-free management of gastrointestinal bleeding: the experience of a Bloodless Institute. (abre uma nova janela)

Sharma P, Barajas FJ, Krishnamoorthy P, Campo LM, Blumenthal E, Spinnell M.

Fonte‎: J Clin Gastroenterol 2015;49(3):206-11.

Indexado‎: PubMed 25144897

DOI‎: 10.1097/MCG.0000000000000200

https://www.ncbi.nlm.nih.gov/pubmed/25144897 (abre uma nova janela)

Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial. (abre uma nova janela)

Silver M, Corwin MJ, Bazan A, Gettinger A, Enny C, Corwin HL.

Fonte‎: Crit Care Med 2006;34(9):2310-6.

Indexado‎: PubMed 16878035

DOI‎: 10.1097/01.CCM.0000233873.17954.42

https://www.ncbi.nlm.nih.gov/pubmed/16878035 (abre uma nova janela)